Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 2
2019 1
2020 8
2021 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Idiopathic pulmonary fibrosis: pathogenesis and management.
Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Sgalla G, et al. Among authors: iovene b. Respir Res. 2018 Feb 22;19(1):32. doi: 10.1186/s12931-018-0730-2. Respir Res. 2018. PMID: 29471816 Free PMC article. Review.
Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management.
Varone F, Iovene B, Sgalla G, Calvello M, Calabrese A, Larici AR, Richeldi L. Varone F, et al. Among authors: iovene b. Lung. 2020 Jun;198(3):429-440. doi: 10.1007/s00408-020-00360-3. Epub 2020 May 15. Lung. 2020. PMID: 32415523 Review.
Investigational drugs for idiopathic pulmonary fibrosis.
Varone F, Montemurro G, Macagno F, Calvello M, Conte E, Intini E, Iovene B, Leone PM, Mari PV, Richeldi L. Varone F, et al. Among authors: iovene b. Expert Opin Investig Drugs. 2017 Sep;26(9):1019-1031. doi: 10.1080/13543784.2017.1364361. Epub 2017 Aug 10. Expert Opin Investig Drugs. 2017. PMID: 28777013 Review.
Nintedanib for the treatment of idiopathic pulmonary fibrosis.
Varone F, Sgalla G, Iovene B, Bruni T, Richeldi L. Varone F, et al. Among authors: iovene b. Expert Opin Pharmacother. 2018 Feb;19(2):167-175. doi: 10.1080/14656566.2018.1425681. Epub 2018 Jan 12. Expert Opin Pharmacother. 2018. PMID: 29327616 Review.
Suggestions for lung function testing in the context of COVID-19.
Milanese M, Corsico AG, Bellofiore S, Carrozzi L, Di Marco F, Iovene B, Richeldi L, Sanna A, Santus P, Schisano M, Scichilone N, Vancheri C, Cerveri I; SIP (Italian Respiratory Society). Milanese M, et al. Among authors: iovene b. Respir Med. 2021 Feb;177:106292. doi: 10.1016/j.rmed.2020.106292. Epub 2020 Dec 31. Respir Med. 2021. PMID: 33440299 Free PMC article. Review.
Residual respiratory impairment after COVID-19 pneumonia.
Lombardi F, Calabrese A, Iovene B, Pierandrei C, Lerede M, Varone F, Richeldi L, Sgalla G; Gemelli Against COVID-19 Post-Acute Care Study Group. Lombardi F, et al. Among authors: iovene b. BMC Pulm Med. 2021 Jul 17;21(1):241. doi: 10.1186/s12890-021-01594-4. BMC Pulm Med. 2021. PMID: 34273962 Free PMC article.
Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio Region.
Di Bidino R, Rogliani P, Sebastiani A, Ricci A, Varone F, Sgalla G, Iovene B, Bruni T, Flore MC, D'Ascanio M, Cavalli F, Savi D, Di Michele L, Cicchetti A, Richeldi L. Di Bidino R, et al. Among authors: iovene b. Front Med (Lausanne). 2022 Jun 9;9:861076. doi: 10.3389/fmed.2022.861076. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35755040 Free PMC article.
19 results